Published in Infect Control Hosp Epidemiol on February 01, 2001
Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol (2002) 3.13
Purification and reconstitution of functional lactose carrier from Escherichia coli. J Biol Chem (1981) 2.93
Purification, reconstitution, and characterization of the lac permease of Escherichia coli. Methods Enzymol (1986) 2.32
Solubilization and reconstitution of the lactose transport system from Escherichia coli. J Biol Chem (1980) 1.81
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol (1987) 1.69
Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol (2001) 1.68
Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A (1985) 1.54
Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol (1992) 1.42
Properties of a phosphoenolpyruvate: mannitol phosphotransferase system in Spirochaeta aurantia. J Biol Chem (1977) 1.35
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine (1994) 1.28
Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr Biol (1998) 1.20
Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol (2000) 1.17
Lactose-proton symport by purified lac carrier protein. Biochemistry (1982) 1.14
Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine (1995) 1.06
Solubilization and reconstitution of the melibiose carrier from a plasmid-carrying strain of Escherichia coli. J Biol Chem (1982) 1.04
Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen. J Biol Chem (1989) 1.04
A versatile synthetic peptide-based ELISA for identifying antibody epitopes. J Immunol Methods (1994) 1.03
Changing pattern of bacterial isolates and antimicrobial susceptibility in neonatal infections in Korle Bu Teaching Hospital, Ghana. East Afr Med J (2007) 0.95
Concurrent infection of human macrophages with HIV-1 and Mycobacterium avium results in decreased cell viability, increased M. avium multiplication and altered cytokine production. J Immunol (1993) 0.95
Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases. Biochemistry (2001) 0.91
Implications of Solar Evolution for the Earth's Early Atmosphere. Science (1977) 0.86
Tick resistance and the major histocompatibility system. Aust J Exp Biol Med Sci (1984) 0.86
A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice. Vaccine (2000) 0.85
Two closely linked loci and one apparently independent locus code for bovine lymphocyte antigens. Tissue Antigens (1982) 0.84
Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells. Cancer Res (1986) 0.84
Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs. AIDS Res Hum Retroviruses (1995) 0.84
Stimulation of maternal anti-lymphocyte antibodies by first gestation bovine fetuses. J Reprod Fertil (1980) 0.83
Analysis of alloantisera against bovine lymphocytes. Joint report of the 1st International Bovine Lymphocyte Antigen (BoLA) workshop. Anim Blood Groups Biochem Genet (1979) 0.83
Type V collagen is an epithelial cell cycle inhibitor that is induced by and mimics the effects of transforming growth factor beta1. Cell Growth Differ (1998) 0.82
In vitro measurement of antigen-specific cell-mediated immune responses using recombinant HIV-1 proteins adsorbed to latex microspheres. J Immunol Methods (1991) 0.81
Systematic development of a block copolymer adjuvant for trivalent influenza virus vaccine. Dev Biol Stand (1998) 0.81
BoLA antigens are associated with increased frequency of persistent lymphocytosis in bovine leukaemia virus infected cattle and with increased incidence of antibodies to bovine leukaemia virus. Anim Genet (1988) 0.81
Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations. Vaccine (1997) 0.81
Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons . AIDS Res Hum Retroviruses (1994) 0.81
Serological and genetic identification of a bovine B lymphocyte alloantigen system. Anim Blood Groups Biochem Genet (1982) 0.80
Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin Cancer Res (1997) 0.80
Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1. In Vitro Cell Dev Biol (1990) 0.79
Molecular mechanics and antibody binding in the structural analysis of polycyclic aromatic hydrocarbon-diol-epoxide--DNA adducts. Carcinogenesis (1990) 0.78
The influence of acetazolamide and amlodipine on the intracellular sodium content of rat proximal tubular cells. Br J Pharmacol (1994) 0.78
Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta. Cancer Res (1989) 0.78
The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833. Anticancer Res (1997) 0.78
Use of particulate forms of protein antigens to increase the sensitivity of antigen-specific proliferation assays. J Immunol Methods (1993) 0.78
Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses. Vaccine (1999) 0.78
Production of foetally stimulated lymphocytotoxic antibodies by multiparous cows. Anim Blood Groups Biochem Genet (1981) 0.77
High-performance liquid chromatography/NMR spectrometry/mass spectrometry: further advances in hyphenated technology. J Mass Spectrom (1997) 0.77
Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis. J Clin Microbiol (2000) 0.76
Histocompatibility polymorphisms of domestic animals. Adv Vet Sci Comp Med (1983) 0.76
Identification of ethanolamine in rat and gerbil brain tissue extracts by NMR spectroscopy. NMR Biomed (1994) 0.76
Cryopreservation of bovine buffy coat leukocytes for use in immunologic studies. Am J Vet Res (1993) 0.76
The use of high vaginal, endocervical and rectal swabs in the diagnosis of genital infection in association with pre-term labour. Br J Clin Pract (1988) 0.75
Production of foetally stimulated lymphocytotoxic antibodies by primiparous cows. Anim Blood Groups Biochem Genet (1979) 0.75
Use of fixed autologous stimulator cells to correctly present human immunodeficiency virus type 1 viral peptides to nonhuman primate lymphocytes in proliferation and cytotoxic T-lymphocyte assays. Clin Diagn Lab Immunol (1994) 0.75
Mixed lymphocyte reactivity in cattle. Tissue Antigens (1982) 0.75
On-line liquid chromatography coupled with high field NMR and mass spectrometry (LC-NMR-MS): a new technique for drug metabolite structure elucidation. J Pharm Biomed Anal (1997) 0.75
Cerebro--spinal fluid. Why, when & what for? Manit Med Rev (1968) 0.75
Treatment of subacute polyneuritis with corticosteroids. Can J Neurol Sci (1974) 0.75
Vaginal flora of first time urban family planning attendants in Accra, Ghana. West Afr J Med (2005) 0.75
Allogeneic antibody response in cattle. Am J Vet Res (1981) 0.75
Xenogeneic monoclonal antibodies to cell surface antigens of equine lymphocytes. Am J Vet Res (1984) 0.75
Reconstitution of the melibiose carrier of Escherichia coli. Membr Biochem (1985) 0.75
Cryopreservation of equine mononuclear cells for immunological studies. Vet Immunol Immunopathol (1990) 0.75
Potential pathogens in the lower genital tract at manual vacuum aspiration for incomplete abortion in Korle Bu Teaching Hospital, Ghana. East Afr Med J (2004) 0.75
Prenatal diagnosis of genetic disease. Can Med Assoc J (1977) 0.75
Total spinal following labour epidural analgesia managed with non-invasive ventilation. Anaesth Intensive Care (2010) 0.75
Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts. IARC Sci Publ (1988) 0.75
Intrathecal catheters and epidural blood patching. Int J Obstet Anesth (2009) 0.75
Antibodies to the neural cell adhesion molecule disrupt functional recovery in injured nerves. Exp Neurol (1990) 0.75
The antibody response to bovine lymphocyte alloantigens. Vet Immunol Immunopathol (1983) 0.75
Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. Cell Immunol (1994) 0.75
Interstellar cloud material: contribution to planetary atmospheres. Science (1978) 0.75
Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. Virology (1986) 0.75
Preliminary report on the isolation of a dysgonic variety of Microsporum canis together with the normal variety from a cattery. Mycopathologia (1992) 0.75
Novel adjuvants for induction of T-cell and antibody responses to encephalitogenic and regulatory determinants in Lewis rats. Vaccine (1998) 0.75
Efficiency of convection and time variation of the solar constant. Science (1978) 0.75